Macromoltek
YC W18 ↗Austin, US · Founded 2010 · 14 employees · 2 known investors
Macromoltek provides computational modeling and AI-driven antibody design services to biotech and pharmaceutical companies, accelerating the discovery and optimization of therapeutic antibodies. The platform reduces time-to-market and increases the probability of clinical success in drug development.
AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryDeep LearningTherapeuticsin /macromoltek-inc/@macromoltekycombinator.com ↗
Founders & leadership· Y Combinator alumni (W18)
MB
Monica Berrondoin𝕏Founder/CEO
SK
Susana KaufmanninFounder/CTO